Regional differences in prevalence of macrolide resistance among pediatric mycoplasma pneumoniae infections in Hokkaido, Japan

Japanese Journal of Infectious Diseases

Volumn 69, Issue 3, 2016, Pages 186-190

  Ishiguro, Nobuhisa ^a,l   Koseki, Naoko ^a,l   Kaiho, Miki ^a,l   Kikuta, Hideaki ^b,l   Togashi, Takehiro ^c,l   Oba, Koji ^d   Morita, Keisuke ^e,l   Nagano, Naoko ^f,l   Nakanishi, Masanori ^g,l   Hazama, Kyosuke ^h,l   Watanabe, Toru ^i,l   Sasaki, Satoshi ^j,l   Horino, Atsuko ^k   Kenri, Tsuyoshi ^k   Ariga, Tadashi ^a,l   Okamura, Akiko ^l   Yamazaki, Shigeru ^l   Shida, Satoru ^l   Kajii, Naofumi ^l   Nagashima, Tetsuo ^l   Yoshioka, Mikio ^l   Takahashi, Yutaka ^l   Konno, Mutsuko ^l   Ishizaka, Akihito ^l   Takebayashi, Takeyasu ^l   Shibata, Mutsuo ^l   Furuyama, Hideto ^l   Sawada, Hiroyuki ^l   Matsuzono, Yoshihiro ^l   Murashita, Mari ^l   Yamanaka, Tatsuru ^l   Naito, Hiroyuki ^l   Akutsu, Yasushi ^l   Aoyagi, Hayato ^l   Tobise, Katsuyuki ^l   Tobise, Chie ^l   Azuma, Katsumi ^l   more..

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Touei Hospital   (Japan)

^c SAPPORO CITY UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e ASAHIKAWA RED CROSS HOSPITAL   (Japan)

^f Nagano Pediatric Clinic   (Japan)

^g Kushiro Red Cross Hospital   (Japan)

^h Hazama Pediatric Clinic   (Japan)

ⁱ Watanabe Kazuhiko Pediatric Clinic   (Japan)

^j Department of Internal Medicine Aiiku Hospital   (Japan)

^k NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; ANTIINFECTIVE AGENT; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; POINT MUTATION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; BACTERIAL GENE; DRUG EFFECTS; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMONIA, MYCOPLASMA;

ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; GENOTYPE; HUMANS; JAPAN; MACROLIDES; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 23S;

EID: 84969263279     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.JJID.2015.054     Document Type: Article

References (27)

1. Principi N, Esposito S, Blasi F, et al. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with communityacquired lower respiratory tract infections. Clin Infect Dis. 2001;32:1281-9.
2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728.
3. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-20.
4. Li X, Atkinson TP, Hagood J, et al. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009; 28:693-6.
5. Hong KB, Choi EH, Lee HJ, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000–2011. Emerg Infect Dis. 2013;19:1281-4.
6. Nilsson AC, Jensen JS, Bjorkman P, et al. Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides. Scand J Infect Dis. 2014;46: 315-9.
7. Caballero Jde D, del Campo R, Mafe Mdel C, et al. First report of macrolide resistance in a Mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain. Antimicrob Agents Chemother. 2014;58:1265-6.
8. Wu PS, Chang LY, Lin HC, et al. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan. Pediatr Pulmonol. 2013;48: 904-11.
9. Dumke R, von Baum H, Luck PC, et al. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010;16:613-6.
10. Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother. 2013;68:506-11.
11. Eshaghi A, Memari N, Tang P, et al. Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010–2011. Emerg Infect Dis. 2013;19:1525-7.
12. Pereyre S, Charron A, Renaudin H, et al. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumo niae clinical strains isolated in France over 12 years. J Clin Microbiol. 2007;45:3534-9.
13. Cardinale F, Chironna M, Chinellato I, et al. Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol. 2013;51:723-4.
14. Spuesens EB, Meijer A, Bierschenk D, et al. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J Clin Microbiol. 2012;50:1999-2004.
15. Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66: 734-7.
16. Zhou Y, Zhang Y, Sheng Y, et al. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2014; 58:1034-8.
17. Ma Z, Zheng Y, Deng J, et al. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China. Pediatr Pulmonol. 2014;49:695-700.
18. Liu X, Jiang Y, Chen X, et al. Drug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics. Biomed Res Int. 2014;2014:320801.
19. Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521-3.
20. Matsuda K, Narita M, Sera N, et al. Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan. BMC Infect Dis. 2013;13:591.
21. Kawai Y, Miyashita N, Kubo M, et al. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother. 2013;57: 4046-9.
22. Miyashita N, Kawai Y, Akaike H, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with communityacquired pneumonia. BMC Infect Dis. 2012;12:126.
23. Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709-12.
24. Winchell JM, Thurman KA, Mitchell SL, et al. Evaluation of three real-time PCR assays for detection ofMycoplasma pneumoniae in an outbreak investigation. J Clin Microbiol. 2008;46: 3116-8.
25. Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624-30.
26. Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965;23:Suppl 1:285+.
27. Cousin-Allery A, Charron A, de Barbeyrac B, et al. Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect. 2000;124:103-11.